{"DataElement":{"publicId":"2954551","version":"1","preferredName":"Disease or Disorder Best Outcome of Therapy Central Nervous System Neoplasm Status Type","preferredDefinition":"A description of the best response to therapy for central nervous system neoplasm.","longName":"2946463v1.0:2954542v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2946463","version":"1","preferredName":"Disease or Disorder Best Outcome of Therapy","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Having the most positive qualities._The result of therapy for a given disease or condition in a patient or group of patients.","longName":"2404658v1.0:3194600v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3194600","version":"1","preferredName":"Best Outcome of Therapy","preferredDefinition":"Having the most positive qualities.:The result of therapy for a given disease or condition in a patient or group of patients.","longName":"C25432:C18919","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Best","conceptCode":"C25432","definition":"Having the most positive qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome of Therapy","conceptCode":"C18919","definition":"The result of therapy for a given disease or condition in a patient or group of patients.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D80CD45-BE7A-5B19-E040-BB89AD430E80","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-03-02","modifiedBy":"ONEDATA","dateModified":"2011-03-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"747EBAC6-25E8-A734-E040-BB89AD43588E","latestVersionIndicator":"Yes","beginDate":"2009-09-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-09-26","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2954542","version":"1","preferredName":"Central Nervous System Neoplasm Status Type","preferredDefinition":"Abnormal growth of cells that comprise the tissues of the central nervous system (brain and spinal cord), without designation of benign or malignant nature._A condition or state at a particular time._Type; a subdivision of a particular kind of thing.","longName":"2954542v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Complete response","valueDescription":"Complete response","ValueMeaning":{"publicId":"3131142","version":"1","preferredName":"Complete response","longName":"3131142","preferredDefinition":"Complete disappearance of all sites of known disease for greater than 4 weeks","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E322D51-E540-3E65-E040-BB89AD430274","latestVersionIndicator":"Yes","beginDate":"2010-08-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-08-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E322D51-E558-3E65-E040-BB89AD430274","beginDate":"2009-10-17","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-08-19","modifiedBy":"ONEDATA","dateModified":"2010-08-19","deletedIndicator":"No"},{"value":"Complete response undetermined","valueDescription":"Complete response undetermined","ValueMeaning":{"publicId":"3131143","version":"1","preferredName":"Complete response undetermined","longName":"3131143","preferredDefinition":"Complete response with persistence of radiographic enhancing abnormalities of\r\nunknown significance","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E322D51-E562-3E65-E040-BB89AD430274","latestVersionIndicator":"Yes","beginDate":"2010-08-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-08-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E322D51-E57B-3E65-E040-BB89AD430274","beginDate":"2009-10-17","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-08-19","modifiedBy":"ONEDATA","dateModified":"2010-08-19","deletedIndicator":"No"},{"value":"No response","valueDescription":"No response","ValueMeaning":{"publicId":"3131145","version":"1","preferredName":"No response","longName":"3131145","preferredDefinition":"Less than 50 percent reduction in greatest diameter of any known sites of disease, and no new sites of disease for greater than 4 weeks","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E322D51-E5A8-3E65-E040-BB89AD430274","latestVersionIndicator":"Yes","beginDate":"2010-08-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-08-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E322D51-E5C1-3E65-E040-BB89AD430274","beginDate":"2009-10-17","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-08-19","modifiedBy":"ONEDATA","dateModified":"2010-08-19","deletedIndicator":"No"},{"value":"Not assessed","valueDescription":"Not Done","ValueMeaning":{"publicId":"3104692","version":"1","preferredName":"Not Done","longName":"3104692v1.00","preferredDefinition":"Indicates a task, process or examination that has either not been initiated or not been completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88084310-6796-6259-E040-BB89AD4311C3","latestVersionIndicator":"Yes","beginDate":"2010-06-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-02","modifiedBy":"RAGUNATHANU","dateModified":"2022-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E322D51-E5CB-3E65-E040-BB89AD430274","beginDate":"2009-10-17","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-08-19","modifiedBy":"ONEDATA","dateModified":"2010-08-19","deletedIndicator":"No"},{"value":"Partial response","valueDescription":"Partial response","ValueMeaning":{"publicId":"3131146","version":"1","preferredName":"Partial response","longName":"3131146","preferredDefinition":"Greater than or equal to 50 percent reduction in greatest diameter of all sites of known disease, and no new sites of disease for greater than 4 weeks","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E322D51-E5D5-3E65-E040-BB89AD430274","latestVersionIndicator":"Yes","beginDate":"2010-08-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-08-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E322D51-E5ED-3E65-E040-BB89AD430274","beginDate":"2009-10-17","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-08-19","modifiedBy":"ONEDATA","dateModified":"2010-08-19","deletedIndicator":"No"},{"value":"Progressive disease","valueDescription":"Progressive disease","ValueMeaning":{"publicId":"3131147","version":"1","preferredName":"Progressive disease","longName":"3131147","preferredDefinition":"Increase in size of any site of known disease, or any new sites of disease.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E322D51-E5F7-3E65-E040-BB89AD430274","latestVersionIndicator":"Yes","beginDate":"2010-08-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-08-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E322D51-E60F-3E65-E040-BB89AD430274","beginDate":"2009-10-17","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-08-19","modifiedBy":"ONEDATA","dateModified":"2010-08-19","deletedIndicator":"No"},{"value":"Continued complete response","valueDescription":"Continued complete response","ValueMeaning":{"publicId":"3287095","version":"1","preferredName":"Continued complete response","longName":"3287095","preferredDefinition":"Continued absence of all disease after a complete response","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE04F386-F977-1095-E040-BB89AD436FF9","latestVersionIndicator":"Yes","beginDate":"2011-09-28","endDate":null,"createdBy":"SORENSENS","dateCreated":"2011-09-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE04F386-FC16-1095-E040-BB89AD436FF9","beginDate":"2009-10-17","endDate":null,"createdBy":"SORENSENS","dateCreated":"2011-09-28","modifiedBy":"ONEDATA","dateModified":"2011-09-28","deletedIndicator":"No"},{"value":"Never treated","valueDescription":"Never Therapeutic Procedure","ValueMeaning":{"publicId":"2685077","version":"1","preferredName":"Never Therapeutic Procedure","longName":"2685077","preferredDefinition":"Not ever; at no time in the past (or future).: An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Never","conceptCode":"C70543","definition":"Not ever; at no time in the past (or future).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B83BB14-A509-653C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-02","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BBECA106-C0FD-4BDA-E040-BB89AD435E39","beginDate":"2012-03-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-03-23","modifiedBy":"ONEDATA","dateModified":"2012-03-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2961487","version":"1","preferredName":"Central Nervous System Neoplasm Status Type","preferredDefinition":"Abnormal growth of cells that comprise the tissues of the central nervous system (brain and spinal cord), without designation of benign or malignant nature.:A condition or state at a particular time.:Type; a subdivision of a particular kind of thing.","longName":"C9293:C25688:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System Neoplasm","conceptCode":"C9293","definition":"A benign or malignant, primary or metastatic neoplasm that affects the brain, meninges, or spinal cord.  Representative examples of primary neoplasms include astrocytoma, oligodendroglioma, ependymoma, and meningioma.  Representative examples of metastatic neoplasms include carcinoma and leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78AC8450-5472-BCA8-E040-BB89AD4336B8","latestVersionIndicator":"Yes","beginDate":"2009-11-18","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-18","modifiedBy":"ONEDATA","dateModified":"2009-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7625C7D8-CD8D-980C-E040-BB89AD435205","latestVersionIndicator":"Yes","beginDate":"2009-10-17","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-10-17","modifiedBy":"KUMMEROA","dateModified":"2012-03-26","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964915","version":"1","longName":"2125r1: Central Nervous System Tumor Post-HSCT Data","context":"NHLBI"},{"publicId":"2964893","version":"1","longName":"2025r1: Central Nervous System Tumor Pre-HSCT Data","context":"NHLBI"},{"publicId":"3279271","version":"1","longName":"Disease Status","context":"NHLBI"}]},{"publicId":"2842912","version":"1","longName":"Therapy","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2842780","version":"1","longName":"General","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"cns_post_tx_rlps_bst_rspn","type":"NMDP_FN","context":"NHLBI"},{"name":"cns_base_tx_bst_rspn_kn","type":"NMDP_FN","context":"NHLBI"},{"name":"cns_post_tx_best_rspn_kn","type":"NMDP_FN","context":"NHLBI"},{"name":"cns_post_dx_best_rspns_kn","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedDiagnosis:diseaseStatusCode ","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the best response of","type":"Preferred Question Text","description":"What was the best response of the CNS neoplasm?","url":null,"context":"NHLBI"},{"name":"What was the best response to HSCT?","type":"Alternate Question Text","description":"What was the best response to HSCT?","url":null,"context":"NHLBI"},{"name":"Best response to line of therapy:","type":"Alternate Question Text","description":"Best response to line of therapy:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2954551","type":"BRIDG Mapping Path","description":"PerformedDiagnosis.diseaseStatusCode WHERE PerformedDiagnosis > AssessedResultRelationship > PerformedObservation > PerformedClinicalinterpretation.value = \"best result\" AND PerformedDiagnosis.value = \"lCNS Neoplasm\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7625C7D8-CE93-980C-E040-BB89AD435205","latestVersionIndicator":"Yes","beginDate":"2009-10-17","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-10-17","modifiedBy":"KUMMEROA","dateModified":"2021-06-17","changeDescription":". 2021-6-17 ak System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}